RxDoctor Payments Data

Ying Liu, MD

Obstetrics & Gynecology · Washington, DCNPI 1437503745

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 79.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,495 and has fallen 61.8% since, to $571 in 2025. Among obstetrics & gynecology clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,342in general payments, 2019–2025

Across 25 payments — averaging $133.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Davol Inc.$277
  • Acera Surgical, Inc.$161
  • Johnson & Johnson$140
  • Pfizer$40
  • Sumitomo Pharma America, Inc.$32
  • plus $51 from 3 others

What the payments were for

  • Travel & lodging$89427%
  • Food & beverage$1,40642%
  • Education$1,01930%
  • Gifts$231%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,342 in reported general payments places this provider in the 90th percentile of 195 obstetrics & gynecology providers in District of Columbia.

See all obstetrics & gynecology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$8,920
Medicare patients
22
Services billed
1,561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Medroxyprogesterone Acetate11$281

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →